Johnson Investment Counsel’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.9M Buy
685,685
+42,733
+7% +$3.74M 0.46% 57
2026
Q1
$54.8M Buy
642,952
+61,899
+11% +$5.52M 0.44% 60
2025
Q4
$45.9M Buy
581,053
+508,087
+696% +$39.8M 0.38% 70
2025
Q3
$5.83M Buy
72,966
+1,360
+2% +$116K 0.05% 157
2025
Q2
$6.51M Sell
71,606
-704
-1% -$64.3K 0.06% 150
2025
Q1
$6.78M Buy
72,310
+1,568
+2% +$140K 0.07% 142
2024
Q4
$6.43M Sell
70,742
-2,323
-3% -$222K 0.06% 144
2024
Q3
$7.58M Sell
73,065
-4,092
-5% -$417K 0.07% 135
2024
Q2
$7.49M Sell
77,157
-7,063
-8% -$652K 0.08% 133
2024
Q1
$7.58M Buy
84,220
+4,536
+6% +$384K 0.08% 132
2023
Q4
$6.35M Sell
79,684
-2,571
-3% -$193K 0.07% 135
2023
Q3
$5.85M Sell
82,255
-2,077
-2% -$155K 0.08% 134
2023
Q2
$6.5M Sell
84,332
-3,057
-3% -$237K 0.08% 129
2023
Q1
$6.57M Sell
87,389
-5,624
-6% -$418K 0.09% 125
2022
Q4
$7.33M Sell
93,013
-3,137
-3% -$235K 0.1% 120
2022
Q3
$6.75M Sell
96,150
-6,525
-6% -$512K 0.1% 118
2022
Q2
$8.23M Sell
102,675
-2,170
-2% -$170K 0.12% 113
2022
Q1
$7.95M Sell
104,845
-13,848
-12% -$1.1M 0.1% 122
2021
Q4
$10.1M Sell
118,693
-21,310
-15% -$1.66M 0.12% 108
2021
Q3
$10.6M Sell
140,003
-25,398
-15% -$2.02M 0.14% 101
2021
Q2
$13.5M Sell
165,401
-206,586
-56% -$16.9M 0.19% 87
2021
Q1
$29.3M Sell
371,987
-264,909
-42% -$20.8M 0.44% 67
2020
Q4
$54.5M Sell
636,896
-126,759
-17% -$10.5M 0.91% 39
2020
Q3
$58.9M Sell
763,655
-2,327
-0.3% -$177K 1.09% 23
2020
Q2
$56.1M Buy
765,982
+24,215
+3% +$1.72M 1.13% 19
2020
Q1
$49.2M Buy
741,767
+34,319
+5% +$2.42M 1.09% 23
2019
Q4
$48.7M Buy
707,448
+188,703
+36% +$12.9M 0.92% 34
2019
Q3
$38.1M Buy
518,745
+752
+0.1% +$54.6K 0.76% 48
2019
Q2
$37.1M Buy
517,993
+14,280
+3% +$1.01M 0.77% 44
2019
Q1
$34.5M Buy
503,713
+104,950
+26% +$6.78M 0.74% 43
2018
Q4
$23.7M Buy
398,763
+373,842
+1,500% +$23.4M 0.58% 49
2018
Q3
$1.67M Buy
24,921
+2,497
+11% +$166K 0.04% 234
2018
Q2
$1.45M Sell
22,424
-380
-2% -$24.9K 0.04% 236
2018
Q1
$1.63M Sell
22,804
-648
-3% -$46.6K 0.04% 196
2017
Q4
$1.77M Buy
23,452
+143
+0.6% +$10.4K 0.04% 197
2017
Q3
$1.7M Sell
23,309
-917
-4% -$66.1K 0.04% 188
2017
Q2
$1.79M Buy
24,226
+838
+4% +$62.2K 0.05% 178
2017
Q1
$1.71M Sell
23,388
-335
-1% -$23.4K 0.05% 173
2016
Q4
$1.55M Buy
23,723
+545
+2% +$37.4K 0.05% 176
2016
Q3
$1.72M Sell
23,178
-419
-2% -$31K 0.06% 171
2016
Q2
$1.73M Sell
23,597
-500
-2% -$35.6K 0.06% 178
2016
Q1
$1.7M Buy
24,097
+308
+1% +$20.5K 0.06% 168
2015
Q4
$1.58M Sell
23,789
-915
-4% -$60.9K 0.06% 177
2015
Q3
$1.57M Sell
24,704
-93
-0.4% -$6.08K 0.06% 181
2015
Q2
$1.62M Sell
24,797
-2,843
-10% -$193K 0.05% 179
2015
Q1
$1.92M Buy
27,640
+358
+1% +$24.7K 0.06% 164
2014
Q4
$1.89M Buy
27,282
+1,242
+5% +$83.9K 0.06% 163
2014
Q3
$1.7M Sell
26,040
-600
-2% -$39.6K 0.06% 162
2014
Q2
$1.82M Buy
26,640
+37
+0.1% +$2.48K 0.06% 143
2014
Q1
$1.73M Sell
26,603
-8,337
-24% -$525K 0.06% 143
2013
Q4
$2.28M Buy
34,940
+6,180
+21% +$396K 0.08% 134
2013
Q3
$1.71M Sell
28,760
-4,454
-13% -$264K 0.07% 140
2013
Q2
$1.9M Buy
+33,214
New +$1.97M 0.08% 131

Other funds holding CL

Johnson Investment Counsel's CL Position: Q2 2026 in Review

Johnson Investment Counsel increased its Colgate-Palmolive (CL) stake by 6.6% in Q2 2026, buying an estimated $3.74M and bringing the position to 685,685 shares worth $62.9M. The position accounts for 0.46% of the portfolio, ranked #57.

Johnson Investment Counsel first reported a position in CL in Q2 2013 and has held it in 53 quarters since. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Johnson Investment Counsel held 685,685 shares of Colgate-Palmolive worth $62.9M as of Q2 2026.
  • Johnson Investment Counsel bought 42,733 Colgate-Palmolive shares in Q2 2026, an estimated $3.74M.
  • Colgate-Palmolive made up 0.46% of Johnson Investment Counsel's portfolio in Q2 2026, its #57 holding.
  • Johnson Investment Counsel first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.